| Soluble Guanylate Cyclase α1–Deficient Mice: A Novel Murine Model for Primary Open Angle Glaucoma ES Buys, YC Ko, C Alt, SR Hayton, A Jones, LT Tainsh, R Ren, A Giani, ... PloS one 8 (3), e60156, 2013 | 70 | 2013 |
| Midkine-A functions upstream of Id2a to regulate cell cycle kinetics in the developing vertebrate retina J Luo, RA Uribe, S Hayton, AA Calinescu, JM Gross, PF Hitchcock Neural development 7, 1-16, 2012 | 49 | 2012 |
| PKCβ inhibitors attenuate amphetamine-stimulated dopamine efflux AG Zestos, SR Mikelman, RT Kennedy, ME Gnegy ACS chemical neuroscience 7 (6), 757-766, 2016 | 41 | 2016 |
| Genetic modifiers of hypertension in soluble guanylate cyclase α1–deficient mice ES Buys, MJ Raher, A Kirby, S Mohd, DM Baron, SR Hayton, LT Tainsh, ... The Journal of clinical investigation 122 (6), 2316-2325, 2012 | 38 | 2012 |
| Soluble guanylate cyclase-α1 is required for the cardioprotective effects of inhaled nitric oxide Y Nagasaka, ES Buys, E Spagnolli, AU Steinbicker, SR Hayton, ... American Journal of Physiology-Heart and Circulatory Physiology 300 (4 …, 2011 | 35 | 2011 |
| Amphetamine stimulates movement through thalamocortical glutamate release OS Mabrouk, DZ Semaan, S Mikelman, ME Gnegy, RT Kennedy Journal of neurochemistry 128 (1), 152-161, 2014 | 26 | 2014 |
| Tamoxifen and amphetamine abuse: are there therapeutic possibilities? S Mikelman, N Mardirossian, ME Gnegy Journal of chemical neuroanatomy 83, 50-58, 2017 | 24 | 2017 |
| Androgen-sensitive hypertension associated with soluble guanylate cyclase-α1 deficiency is mediated by 20-HETE AC Dordea, S Vandenwijngaert, V Garcia, RET Tainsh, DI Nathan, K Allen, ... American Journal of Physiology-Heart and Circulatory Physiology 310 (11 …, 2016 | 16 | 2016 |
| Tamoxifen directly interacts with the dopamine transporter SR Mikelman, B Guptaroy, KC Schmitt, KT Jones, J Zhen, MEA Reith, ... Journal of Pharmacology and Experimental Therapeutics 367 (1), 119-128, 2018 | 13 | 2018 |
| Tamoxifen and its active metabolites inhibit dopamine transporter function independently of the estrogen receptors SR Mikelman, B Guptaroy, ME Gnegy Journal of Neurochemistry 141 (1), 31-36, 2017 | 11 | 2017 |
| Nitric oxide synthase 3 deficiency limits adverse ventricular remodeling after pressure overload in insulin resistance B Kurtz, HB Thibault, MJ Raher, JR Popovich, S Cawley, DN Atochin, ... American Journal of Physiology-Heart and Circulatory Physiology 301 (5 …, 2011 | 10 | 2011 |
| The protein kinase C inhibitor tamoxifen inhibits neurochemical and reinforcing behavioral effects of amphetamine S Mikelman, B Guptaroy, E Jutkiewicz, M Gnegy The FASEB Journal 29, 930.11, 2015 | 2 | 2015 |
| Novel CNS‐Permeant PKC inhibitor and tamoxifen analog reduces amphetamine neurochemical and behavioral effects C Carpenter, S Mikelman, M Gnegy The FASEB Journal 29, 768.16, 2015 | 1 | 2015 |
| Modulation of Dopamine Transporter Function by Tamoxifen SR Mikelman | | 2016 |
| Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE S Vandenwijngaert, AC Dordea, V Garcia, RE Tainsh, DI Nathan, ... BMC Pharmacology and Toxicology 16, 1-1, 2015 | | 2015 |
| INHIBITION OF AMPHETAMINE (AMPH) ACTIVATION BY BRAIN-PERMEABLE PKC INHIBITORS: TAMOXIFEN AND METABOLITES M Gnegy, S Mikelman, C Carpenter, O Mabrouk, R Kennedy BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY 115, 198-198, 2014 | | 2014 |
